Literature DB >> 1747281

Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease.

P H Groves1, N P Lewis, S Ikram, R Maire, R J Hall.   

Abstract

OBJECTIVE: To determine how severe tricuspid regurgitation influences exercise capacity and functional state in patients who have undergone successful mitral valve replacement for rheumatic mitral valve disease.
DESIGN: 9 patients in whom clinically significant tricuspid regurgitation developed late after mitral valve replacement were compared with 9 patients with no clinical evidence of tricuspid regurgitation. The two groups were matched for preoperative clinical and haemodynamic variables. Patients were assessed by conventional echocardiography, Doppler echocardiography, and a maximal treadmill exercise test in which expired gas was monitored by mass spectrometry.
SETTING: University Hospital of Wales, Cardiff.
SUBJECTS: 18 patients who had been reviewed regularly since mitral valve replacement. MAIN OUTCOME MEASURE: Objective indices of exercise performance including exercise duration, maximal oxygen consumption, anaerobic threshold, and ventilatory response to exercise.
RESULTS: Mitral valve prosthetic function was normal in all patients and estimated pulmonary artery systolic pressure and left ventricular function were similar in the two groups. Right ventricular diameter (median (range) 5.0 (4.3-5.6) v 3.7 (3.0-5.4) cm, p less than 0.01) and the incidence of paradoxical septal motion (9/9 v 3/9, p less than 0.01) were greater in the group with severe tricuspid regurgitation. Exercise performance--assessed by exercise duration (6.3 (5.0-10.7) v 12.7 (7.2-16.0) min, p less than 0.01), maximum oxygen consumption (11.2 (7.3-17.8) v 17.7 (11.8-21.4) ml min-1 kg-1, p less than 0.01), and anaerobic threshold (8.3 (4.6-11.4) v 0.7 (7.3-15.5) ml min-1 kg-1, p less than 0.05)--was significantly reduced in the group with severe tricuspid regurgitation. The ventilatory response to exercise was greater in patients with tricuspid regurgitation (minute ventilation at the same minute carbon dioxide production (41.0 (29.9-59.5) v 33.6 (26.8-39.3) l/min, p less than 0.01).
CONCLUSIONS: Clinically significant tricuspid regurgitation may develop late after successful mitral valve replacement and in the absence of residual pulmonary hypertension, prosthetic dysfunction, or significant left ventricular impairment. Patients in whom severe tricuspid regurgitation developed had a considerable reduction in exercise capacity caused by an impaired cardiac output response to exercise and therefore experienced a poor functional outcome. The extent to which this was attributable to the tricuspid regurgitation itself or alternatively to the consequences of right ventricular dysfunction was not clear and requires further investigation.

Entities:  

Mesh:

Year:  1991        PMID: 1747281      PMCID: PMC1024725          DOI: 10.1136/hrt.66.4.295

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  32 in total

1.  Carpentier's annulus and De Vegas annuloplasty. The end of the tricuspid challenge.

Authors:  P Grondin; C Meere; R Limet; L Lopez-Bescos; J L Delcan; R Rivera
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

2.  SURGICAL TREATMENT OF TRICUSPID INSUFFICIENCY.

Authors:  J H KAY; G MASELLI-CAMPAGNA; K K TSUJI
Journal:  Ann Surg       Date:  1965-07       Impact factor: 12.969

3.  Exercise tests before and after heart valve replacement.

Authors:  D G Gilmour; S G Spiro; M J Raphael; S Freedman
Journal:  Br J Dis Chest       Date:  1976-07

4.  The measurement of metabolic gas exchange and minute volume by mass spectrometry alone.

Authors:  N J Davies; D M Denison
Journal:  Respir Physiol       Date:  1979-02

5.  [Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency].

Authors:  N G De Vega
Journal:  Rev Esp Cardiol       Date:  1972 Nov-Dec       Impact factor: 4.753

6.  [Anatomical study of rheumatic tricuspid valve diseases: Application to the study of various valvuloplasties].

Authors:  A Deloche; J Guerinon; J N Fabiani; F Morillo; M Caramanian; A Carpentier; P Maurice; C Dubost
Journal:  Ann Chir Thorac Cardiovasc       Date:  1973-10

7.  A new reconstructive operation for correction of mitral and tricuspid insufficiency.

Authors:  A Carpentier; A Deloche; J Dauptain; R Soyer; P Blondeau; A Piwnica; C Dubost; D C McGoon
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

8.  Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy.

Authors:  R Engler; R Ray; C B Higgins; C McNally; W H Buxton; V Bhargava; R Shabetai
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

9.  Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.

Authors:  L Goldman; B Hashimoto; E F Cook; A Loscalzo
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

10.  Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.

Authors:  N P Buller; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-05
View more
  16 in total

Review 1.  Tricuspid valve repair for treatment and prevention of secondary tricuspid regurgitation in patients undergoing mitral valve surgery.

Authors:  Ani C Anyanwu; Joanna Chikwe; David H Adams
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

Review 2.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 3.  Valve disease: Surgery of valve disease: late results and late complications.

Authors:  P Groves
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Mitral valve restenosis after closed mitral commissurotomy: case discussion.

Authors:  Anyi Xu; Jiang Jin; Xiaodong Li; Jian Xiao; Peng Zhu; Wenhui Gong; Yue Liu; Yuetian Yu; Chunguang Wang; Chengxin Zhang; Irbaz Hameed; Arash Salemi; Daniel Hernandez-Vaquero; Taufiek Konrad Rajab; Francesco Nappi; Jianfei Shen; Baofu Chen
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 5.  Tricuspid regurgitation following left-sided valve surgery: echocardiographic evaluation and optimal timing of surgical treatment.

Authors:  Chisato Izumi
Journal:  J Echocardiogr       Date:  2014-12-09

Review 6.  Tricuspid regurgitation after successful mitral valve surgery.

Authors:  Vasiliki Katsi; Leonidas Raftopoulos; Constantina Aggeli; Ioannis Vlasseros; Ioannis Felekos; Dimitrios Tousoulis; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-28

7.  Mechanism of improvement in exercise capacity after the maze procedure combined with mitral valve surgery.

Authors:  S Yuda; S Nakatani; Y Kosakai; T Satoh; Y Goto; M Yamagishi; K Bando; S Kitamura; K Miyatake
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 8.  Pathophysiology and management of multivalvular disease.

Authors:  Philippe Unger; Marie-Annick Clavel; Brian R Lindman; Patrick Mathieu; Philippe Pibarot
Journal:  Nat Rev Cardiol       Date:  2016-04-28       Impact factor: 32.419

9.  B-type natriuretic Peptide in isolated severe tricuspid regurgitation: determinants and impact on outcome.

Authors:  Chang-Hwan Yoon; Joo-Hee Zo; Yong-Jin Kim; Hyung-Kwan Kim; Dong-Ho Shine; Kyung-Hwan Kim; Ki-Bong Kim; Hyuk Ahn; Dae-Won Sohn; Byung-Hee Oh; Young-Bae Park
Journal:  J Cardiovasc Ultrasound       Date:  2010-12-31

10.  Tricuspid regurgitation: clinical importance and its optimal surgical timing.

Authors:  Hyung-Kwan Kim; Seung-Pyo Lee; Yong-Jin Kim; Dae-Won Sohn
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.